Evidence map›Paper›PMID 36382477›Full record

ArticleBiomolecules & therapeutics2023

Macakurzin C Derivatives as a Novel Pharmacophore for Pan-Peroxisome Proliferator-Activated Receptor Modulator.

Hyejin Ko, Seungchan An, Hongjun Jang, Sungjin Ahn, In Guk Park, Seok Young Hwang, Junpyo Gong, Soyeon Oh, Soo Yeon Kwak, Won Jun Choi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hyejin KoCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Seungchan AnCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Hongjun JangResearch Institute of Pharmaceutical Science and Technology, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
Sungjin AhnCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
In Guk ParkCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Seok Young HwangCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Junpyo GongCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Soyeon OhCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Soo Yeon KwakResearch Institute of Pharmaceutical Science and Technology, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
Won Jun ChoiCollege of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
Hyoungsu KimResearch Institute of Pharmaceutical Science and Technology, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
Minsoo NohCollege of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natural flavonoid macakurzin C (

Indexed as

AdiponectinHuman bone marrow mesenchymal stem cellsMacakurzin C derivativePeroxisome proliferator-activated receptorPPARα/γ dual modulator

Identifiers

PMID36382477
PMCPMC10129854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.